Response of chemosensitive and chemoresistant leukemic cell lines to drug therapy: Simultaneous assessment of proliferation, apoptosis, and necrosis

Communications in Clinical Cytometry

Volumn 42, Issue 1, 2000, Pages 50-60

  Boutonnat, J ^a   Barbier, M ^a   Muirhead, K ^b   Mousseau, M ^c   Grunwald, D ^d   Ronot, X ^a   Seigneurin, D ^a  

^a INSTITUT ALBERT BONNIOT   (France)

^b SciGro Inc   (United States)

^c HÔPITAL MICHALLON   (France)

^d CEA GRENOBLE   (France)

Author keywords

Apoptosis; Chemoresistance; Flow cytometry; PKH67; Proliferation

Indexed keywords

ANTINEOPLASTIC AGENT; DNA; IRINOTECAN; LIPOCORTIN 5;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG SENSITIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LEUKEMIA CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

ANNEXIN A5; ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZIMIDAZOLES; CAMPTOTHECIN; CELL DIVISION; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; LEUKEMIA, MYELOID; NECROSIS; P-GLYCOPROTEIN; PROPIDIUM; TRANEXAMIC ACID; TUMOR CELLS, CULTURED; VINCRISTINE;

EID: 0034652724     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(20000215)42:1<50::AID-CYTO8>3.0.CO;2-C     Document Type: Article

References (22)

1. Belloc F, Dumain P, Boisseau MR, Jaloustre C, Reiffers J, Bernard P, Lacombe F. A flow cytometric method using Hoechst 33342 and propidium iodide for simultaneous cell cycle analysis and apoptosis determination in unfixed cells. Cytometry 1994;17:59-65.
2. Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssiere JL, Petit PX. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 1995;182:367-377.
3. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz M, Lassota P, Traganos F. Features of apoptotic cells measured by flow cytometry. Cytometry 1992;13:795-808.
4. Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehnen RMJ, Pals ST, Van Oers MHJ. Annexin V for flow cytometry detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994;84:1415-1420.
5. Van Engeland M, Nieland LJ, Ramaakers FC, Schutte B, Reutelingsperger CP. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998; 31:1-9.
6. Legrand O, Perrot JY, Tang RP, Simonin G, Gurbuxani S, Zittoun R, Marie JP. Expression of the multidrug resistance-associated protein (MRP) mRNA and protein in normal peripheral blood and bone marrow haemopoietic cells. Br J Haematol 1996;94:23-33.
7. Marie JP, Zhou DC, Gurbuxani S, Legrand O, Zittoun R. MDR1/P-glycoprotein in Haematological neoplasms. Eur J Cancer 1996;32: 1034-1038.
8. Denis Gay M, Petit JM, Ratinaud MH. Rhodamine 123: is it an appropriate dye to study P-glycoprotein activity in adriamycin-resistant K562 cells? Anticancer Res 1995;15:121-126.
9. Loe DW, Deeley RG, Cole SPC. Biology of the multidrug resistance-associated protein, MRP. Eur J Cancer 1996;32:945-957.
10. Webb M, Raphael CL, Asbahr H, Erber WN, Meyer BF. The detection of rhodamine 123 efflux at low levels of drug resistance. Br J Haematol 1996;93:650-655.
11. Horan PK, Melnicoff MJ, Jensen BD, Slezak SE. Fluorescent cell labeling for in vivo and in vitro cell tracking. Methods Cell Biol 1990;33: 469-490.
12. Allsopp CE, Nicholls SJ, Langhorne J. A flow cytometric method to assess antigen-specific proliferative responses of different subpopulations of fresh and cryopreserved human peripheral blood mononuclear cells. J Immunol Methods 1998;214:175-186.
13. Ashley D, Bol S, Waugh C, Kannourakis G. A novel approach to the measurement of different "in vitro" leukaemic cell growth parameters: the use of PKH GL fluorescent probes. Leuk Res 1993;17:873-882.
14. Boyd F. Identification of growth inhibited cells by retention of a lipophilic fluorescent dye. Cell Growth Differ 1993;4:777-784.
15. Yamamura Y, Rodriguez N, Schwartz A, Eylar E, Bagwell B, Yano N. A new flow cytometric method for quantitative assessment of lymphocyte mitogenic potentials. Cell Mol Biol 1995;41:121-132.
16. Young J, Varma A, DiGuisto D, Backer M. Retention of quiescent hematopoietic cells with high proliferative potential during ex vivo stem cell culture. Blood 1996;87:545-556.
17. Boutonnat J, Barbier M, Seigneurin D, Muirhead KA, Rousselle C, Ronot X. The use of PKH26 and 67 for cell proliferation assessment in chemosensitive and chemoresistant cells. Eur J Microsc Anal 1998; 56:17-19.
18. Lyons AB, Doherty KV. Flow cytometric analysis of cell division by dye dilution. In: Robinson P, editor. Current protocols in cytometry, supplement 6, section 9.11.5. 1998. New York: John Wiley & Sons, Inc.
19. Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell line with positive philadelphia chromosome. Blood 1975;45:321-334.
20. Banker DE, Groudine M, Willman CL, Norwood T, Appelbaum FR. Cell cycle perturbations in acute myeloid leukemia samples following "in vitro" exposures to therapeutic agents. Leuk Res 1998;22:221-239.
21. Boutonnat J, Muirhead KA, Barbier M, Mousseau M, Ronot X, Seigneurin D. PKH26 probe in the study of the proliferation of chemoresistant leukemic sublines. Anticancer Res 1998;18:4243-4252.
22. Te Boekhorst PA, Lowenberg B, van Kapel J, Nooter K, Sonneveld P. Multidrug resistant cells with high proliferative capacity determine response to therapy in acute myeloid leukemia. Leukemia 1995;9: 1025-1031.